Post-approval studies (Phase 4)Study completedNCT01084278What this trial is testingHealthy and Renal Impairment Study of Colcrys (Colchicine, USP)Who this might be right forPharmacokinetics Takeda 40
Early research (Phase 1)Study completedNCT05112419What this trial is testingAssess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal ImpairmentWho this might be right forHepatic ImpairmentRenal Impairment AstraZeneca 12
Testing effectiveness (Phase 2)Study completedNCT02742103What this trial is testingCSL112 in Adults With Moderate Renal Impairment and Acute Myocardial InfarctionWho this might be right forAcute Myocardial InfarctionModerate Renal Impairment CSL Behring 83
Early research (Phase 1)Ended earlyNCT06639087What this trial is testingA Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal ImpairmentWho this might be right forRenal ImpairmentHeart Failure AstraZeneca 8
Not applicableEnded earlyNCT04020458What this trial is testingDental Intervention Plan for Chronic Kidney Disease Patients Awaiting or With Kidney TransplantWho this might be right forChronic Kidney DiseaseChronic Periodontitis, Generalized, Moderate Augusta University 11
Post-approval studies (Phase 4)Study completedNCT01770652What this trial is testingAn Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal ImpairmentWho this might be right forRenal Impairment ApoPharma 32
Testing effectiveness (Phase 2)Ended earlyNCT00581269What this trial is testingDietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease Vanderbilt University 3
Early research (Phase 1)Ended earlyNCT01359579What this trial is testingThe Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal FunctionWho this might be right forRenal Impairment Anthera Pharmaceuticals 28
Early research (Phase 1)Study completedNCT03302091What this trial is testingA Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the BodyWho this might be right forRenal InsufficiencyHealthy Boehringer Ingelheim 20
Large-scale testing (Phase 3)Study completedNCT03242252What this trial is testingSafety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar ControlWho this might be right forType 2 Diabetes MellitusChronic Kidney Disease Stage 3 Lexicon Pharmaceuticals 787
Not applicableStudy completedNCT05257668What this trial is testingIntradialytic High-Intensity Interval Training in Hemodialysis PatientsWho this might be right forEnd Stage Renal DiseaseExercise, Compulsive Yasemin ASLAN KELEŞ 69
Early research (Phase 1)Study completedNCT02011490What this trial is testingPharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)Who this might be right forRenal InsufficiencyRenal Impairment Merck Sharp & Dohme LLC 33
Not applicableStudy completedNCT04579315What this trial is testingLong-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease(CKD)HyperphosphatemiaBlood Pressure Bo Feldt-Rasmussen 60
Early research (Phase 1)Study completedNCT02199379What this trial is testingA Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy SubjectsWho this might be right forRenal ImpairmentDisease Severity Eisai Inc. 26
Early research (Phase 1)Study completedNCT01708889What this trial is testingPharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionWho this might be right forChronic Hepatitis B Virus InfectionChronic Hepatitis C Virus Infection Bristol-Myers Squibb 43
Early research (Phase 1)Study completedNCT06547502What this trial is testingPharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal ImpairmentWho this might be right forDiabetes Gan and Lee Pharmaceuticals, USA 16
Early research (Phase 1)Study completedNCT03087942What this trial is testingPharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy SubjectsWho this might be right forRenal Insufficiency Novartis Pharmaceuticals 45
Early research (Phase 1)Study completedNCT00567047What this trial is testingPharmacokinetic Study of Vildagliptin in Patients With Renal ImpairmentWho this might be right forType-2 Diabetes Novartis 96
Testing effectiveness (Phase 2)Study completedNCT02128490What this trial is testingEfficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentWho this might be right forGoutModerate Renal Impairment Takeda 189
Early research (Phase 1)Study completedNCT00750620What this trial is testingA Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentWho this might be right forRenal Impairment Astellas Pharma Inc 33